Liu QZ - Search Results

1

Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment.

Yan K, Liu QZ, Huang RR, Jiang YH, Bian ZH, Li SJ, Li L, Shen F, Tsuneyama K, Zhang QL, Lian ZX, Guan H, Xu B. Yan K, et al. Among authors: liu qz. Clin Transl Med. 2024 Mar;14(3):e1594. doi: 10.1002/ctm2.1594. Clin Transl Med. 2024. PMID: 38426403 Free PMC article.

2

Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.

Guo M, Chen Z, Li Y, Li S, Shen F, Gan X, Feng J, Cai W, Liu Q, Xu B. Guo M, et al. Front Endocrinol (Lausanne). 2021 Jun 23;12:674616. doi: 10.3389/fendo.2021.674616. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34248843 Free PMC article.

3

Immune profiling identifies CD8⁺ T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer.

Chen Z, Guo ML, Li YY, Yan K, Li L, Shen F, Guan H, Liu QZ, Xu B, Lian ZX. Chen Z, et al. Among authors: liu qz. Front Immunol. 2022 Nov 7;13:894919. doi: 10.3389/fimmu.2022.894919. eCollection 2022. Front Immunol. 2022. PMID: 36420264 Free PMC article.

4

Multi-omics analysis identifies FoxO1 as a regulator of macrophage function through metabolic reprogramming.

Yan K, Da TT, Bian ZH, He Y, Liu MC, Liu QZ, Long J, Li L, Gao CY, Yang SH, Zhao ZB, Lian ZX. Yan K, et al. Among authors: liu mc, liu qz. Cell Death Dis. 2020 Sep 24;11(9):800. doi: 10.1038/s41419-020-02982-0. Cell Death Dis. 2020. PMID: 32973162 Free PMC article.

5

FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.

Yang JB, Zhao ZB, Liu QZ, Hu TD, Long J, Yan K, Lian ZX. Yang JB, et al. Among authors: liu qz. Oncogene. 2018 Mar;37(9):1192-1204. doi: 10.1038/s41388-017-0048-4. Epub 2017 Dec 14. Oncogene. 2018. PMID: 29238041

6

Gut microbiota translocation promotes autoimmune cholangitis.

Ma HD, Zhao ZB, Ma WT, Liu QZ, Gao CY, Li L, Wang J, Tsuneyama K, Liu B, Zhang W, Zhou Y, Gershwin ME, Lian ZX. Ma HD, et al. Among authors: liu qz, liu b. J Autoimmun. 2018 Dec;95:47-57. doi: 10.1016/j.jaut.2018.09.010. Epub 2018 Oct 17. J Autoimmun. 2018. PMID: 30340822 Free PMC article.

7

Gut microbiota contributes to sexual dimorphism in murine autoimmune cholangitis.

Huang MX, Yang SY, Luo PY, Long J, Liu QZ, Wang J, He Y, Li L, Zhao ZB, Lian ZX. Huang MX, et al. Among authors: liu qz. J Leukoc Biol. 2021 Dec;110(6):1121-1130. doi: 10.1002/JLB.3MA0321-037R. Epub 2021 May 28. J Leukoc Biol. 2021. PMID: 34047390

8

Adaptive immune cells are necessary for the enhanced therapeutic effect of sorafenib-loaded nanoparticles.

Zhao ZB , Long J , Zhao YY , Yang JB , Jiang W , Liu QZ , Yan K , Li L , Wang YC , Lian ZX . Zhao ZB , et al. Among authors: liu qz. Biomater Sci. 2018 Mar 26;6(4):893-900. doi: 10.1039/c8bm00106e. Biomater Sci. 2018. PMID: 29512660

9

The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis via CD8⁺ T Cells but Promotes Colitis via CD4⁺ T Cells.

Liu QZ, Ma WT, Yang JB, Zhao ZB, Yan K, Yao Y, Li L, Miao Q, Gershwin ME, Lian ZX. Liu QZ, et al. Front Immunol. 2018 May 17;9:1090. doi: 10.3389/fimmu.2018.01090. eCollection 2018. Front Immunol. 2018. PMID: 29868034 Free PMC article.

10

Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8⁺ T cell activation.

Ma HD, Ma WT, Liu QZ, Zhao ZB, Liu MZ, Tsuneyama K, Gao JM, Ridgway WM, Ansari AA, Gershwin ME, Fei YY, Lian ZX. Ma HD, et al. Among authors: liu qz, liu mz. J Autoimmun. 2017 Mar;78:19-28. doi: 10.1016/j.jaut.2016.12.012. Epub 2017 Jan 24. J Autoimmun. 2017. PMID: 28129932 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters